Trial · NCT01291056
Differential Effects of Clomiphene Citrate in Women Undergoing Superovulation
NCT01291056, Not applicable, Completed, University of Utah; results first posted 2016-06-28
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Differential Effects of Clomiphene Citrate in Women Undergoing Superovulation. Trials, record NCT01291056. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01291056
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Differential Effects of Clomiphene Citrate in Women Undergoing Superovulation
- NCT number
- NCT01291056
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 20 participants, actual
- Lead sponsor
- University of Utah
- Conditions
- Mood
- Interventions
- Placebo, Clomiphene
- First posted
- 2011-02-07
- Last updated
- 2016-06-28
- Results first posted
- 2016-06-28
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Follicular Cycle Total Behavioral Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | 1 year | To identify behavioral symptoms experienced by women taking clomiphene citrate versus placebo for superovulation in a prospective setting. |
| Primary | Follicular Cycle Total Physical Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | 1 Year | To identify physical symptoms experienced by women taking clomiphene citrate versus placebo for superovulation in a prospective setting. |
| Primary | Luteal Cycle Total Behavioral Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | 1 year | To identify behavioral symptoms experienced by women taking clomiphene citrate versus placebo for superovulation in a prospective setting. |
| Primary | Luteal Cycle Total Physical Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | 1 year | To identify physical symptoms experienced by women taking clomiphene citrate versus placebo for superovulation in a prospective setting. |
Source ClinicalTrials.gov
Outcomes4
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Follicular Cycle Total Behavioral Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | 1 year | The scale incorporates physical, behavioral and mental symptoms. Each participant will rate the symptom(s) from zero to three based off severity. Symptoms with zero means that no symptoms are present. Symptoms with three means that the symptoms are severe. Range 0 -75 per cycle day. | units on a scale | MEDIAN |
| PRIMARY | Follicular Cycle Total Physical Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | 1 Year | The scale incorporates physical, behavioral and mental symptoms. Each participant will rate the symptom(s) from zero to three based off severity. Symptoms with zero means that no symptoms are present. Symptoms with three means that the symptoms are severe. Range 0 -75 per cycle day. | units on a scale | MEDIAN |
| PRIMARY | Luteal Cycle Total Behavioral Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | 1 year | The scale incorporates physical, behavioral and mental symptoms. Each participant will rate the symptom(s) from zero to three based off severity. Symptoms with zero means that no symptoms are present. Symptoms with three means that the symptoms are severe. Range 0 -75 per cycle day. | units on a scale | MEDIAN |
| PRIMARY | Luteal Cycle Total Physical Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | 1 year | The scale incorporates physical, behavioral and mental symptoms. Each participant will rate the symptom(s) from zero to three based off severity. Symptoms with zero means that no symptoms are present. Symptoms with three means that the symptoms are severe. Physical symptoms were calculated to give the total score. Range 0 -75 per cycle day. | units on a scale | MEDIAN |
Source ClinicalTrials.gov
Results by group8
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Follicular Cycle Total Behavioral Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | Clomiphene Citrate | 3 | Full Range 0 to 6 | units on a scale | |
| Follicular Cycle Total Behavioral Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | Placebo | 5 | Full Range 1 to 18 | units on a scale | |
| Follicular Cycle Total Physical Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | Clomiphene Citrate | 10 | Full Range 2.25 to 14 | units on a scale | |
| Follicular Cycle Total Physical Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | Placebo | 8 | Full Range 5 to 26 | units on a scale | |
| Luteal Cycle Total Behavioral Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | Clomiphene Citrate | 5 | Full Range 0 to 14.5 | units on a scale | |
| Luteal Cycle Total Behavioral Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | Placebo | 2 | Full Range 0 to 13 | units on a scale | |
| Luteal Cycle Total Physical Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | Clomiphene Citrate | 9 | Full Range 3.25 to 15 | units on a scale | |
| Luteal Cycle Total Physical Score for Calendar of Premenstrual Experiences (COPE) Self Assessment | Placebo | 9 | Full Range 0 to 28 | units on a scale |
Source ClinicalTrials.gov
Participant flow18
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Intervention One (Menstraution Day 3-7) | STARTED | Clomiphene Citrate, Then Placebo | 10 | |
| Intervention One (Menstraution Day 3-7) | STARTED | Placebo, Then Clomiphene Citrate | 10 | |
| Intervention One (Menstraution Day 3-7) | COMPLETED | Clomiphene Citrate, Then Placebo | 10 | |
| Intervention One (Menstraution Day 3-7) | COMPLETED | Placebo, Then Clomiphene Citrate | 10 | |
| Intervention One (Menstraution Day 3-7) | NOT COMPLETED | Clomiphene Citrate, Then Placebo | 0 | |
| Intervention One (Menstraution Day 3-7) | NOT COMPLETED | Placebo, Then Clomiphene Citrate | 0 | |
| Washout | STARTED | Clomiphene Citrate, Then Placebo | 10 | |
| Washout | STARTED | Placebo, Then Clomiphene Citrate | 10 | |
| Washout | COMPLETED | Clomiphene Citrate, Then Placebo | 10 | |
| Washout | COMPLETED | Placebo, Then Clomiphene Citrate | 10 |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 participant flowAdverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Clomiphene Citrate, Then Placebo | ||
| Total, all-cause mortality | Placebo, Then Clomiphene Citrate | ||
| Total, other adverse events | Clomiphene Citrate, Then Placebo | 0 | 10 |
| Total, other adverse events | Placebo, Then Clomiphene Citrate | 0 | 10 |
| Total, serious adverse events | Clomiphene Citrate, Then Placebo | 0 | 10 |
| Total, serious adverse events | Placebo, Then Clomiphene Citrate | 0 | 10 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Clomiphene Citrate, Then Placebo vs Placebo, Then Clomiphene Citrate: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01291056
GET https://conductscience.org/api/trials/v1/NCT01291056/registered